2025 Outlook Q&A: ACA Group’s Carlo di Florio on Regulation

With President-elect Donald Trump about to enter a second (non-consecutive) time period as president, federal regulation…

Reflections on 2024: Increasing What’s Attainable

As we mirror on 2024, we’re struck by how a lot can change in a yr…

Banks Again on the Street to Restoration

Banks have been deeply out of favor for a very long time. Actually, you’ll be able…

2024 12 months in Evaluate: One other New Fiduciary Rule

One other 12 months, one other fiduciary rule. And one other courtroom struggle over it. The…

Speaking to Purchasers About ESG Investing

Over the previous 10 years, environmental, social, and governance (ESG) investing has developed from a distinct…

How Tech Empowers Advisors to be Mechanics and Guides

Advisors play a twin position as mechanics, bringing technical experience to advanced monetary issues, and as…

Will the Biogen Drug Approval Be a Boon for Biotech?

Final week, the FDA accredited Biogen’s Alzheimer’s drug candidate, aducanumab (marketed as Aduhelm). This approval appears…

Methods for Success in Wealth Administration

On this insightful webinar, we’ll discover the evolving panorama of serving high-net-worth (HNW) purchasers within the…

Two Advisors Give Life to Their Shared Imaginative and prescient for an RIA-Solely Enterprise

Based in 1979, Commonwealth Monetary Community®, Member FINRA/SIPC, a Registered Funding Adviser, supplies monetary advisors with…

Animal Spirits: All In on US Shares

As we speak’s Animal Spirits is delivered to you by YCharts and Cloth: See right here…